🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liver Transplant, Complications

Faecal Microbiota Transplantation for Liver Cirrhosis NCT04932577Phase 2, Phase 31 site📍 Aarhus University of Aarhus · Tests: Faecal microbiota transplantation, Placebo Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue NCT07102550Phase 21 site📍 Cleveland Jaekeun Kim · Tests: MiMedx AmnioFix Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications NCT07715500NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: Magnetic Resonance Cholangiopancreatography Extended-Release Tacrolimus Following Liver Transplantation NCT05242315Phase 41 site📍 Edmonton University of Alberta · Tests: Envarsus Oral Product, Prograf (SOC) Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation NCT07291258n/a1 site📍 Groningen University Medical Center Groningen Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation NCT06535945Phase 48 sites📍 Chambray-lès-Tours📍 Clichy📍 Lille Rennes University Hospital · Tests: Albumin administration Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors NCT03803423NA6 sites📍 San Diego📍 New Haven📍 Chicago Johns Hopkins University · Tests: The Donor App Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus NCT06060392NA1 site📍 Gurgaon Medanta, The Medicity, India · Tests: Semaglutide Pill HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients NCT06386198NA2 sites📍 San Francisco📍 Atlanta University of California, San Francisco · Tests: Health Advocate Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation NCT06782880NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Fecal microbiota transplantation (FMT) Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment NCT05326399n/a2 sites📍 Shanghai📍 Shanghai RenJi Hospital · Tests: renal biospy Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children NCT06048445n/a1 site📍 Hangzhou Zhejiang University · Tests: intraoperative plancement of Biliary Drainage Stent CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites📍 Klagenfurt📍 Vienna📍 Aachen CytoSorbents, Inc · Tests: CytoSorb Preoperative Prehabilitation in Patients Planned for Liver Transplantation NCT06808945NA1 site📍 Rotterdam Erasmus Medical Center · Tests: Prehabilitation program EBD RCT Trial in Living Donor Liver Transplantation NCT04622540NA1 site📍 Seoul Seoul National University Hospital · Tests: External biliary drainage Immune Biomarkers for Predicting Complications After Liver Transplantation NCT07875595n/a3 sites📍 Pilar📍 Buenos Aires📍 Buenos Aires Hospital Italiano de Buenos Aires · Tests: Immune Biomarker Assessment Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation NCT06236568NA1 site📍 Modena Azienda Ospedaliero-Universitaria di Modena · Tests: D-HOPE machine perfusion, Liver transplantation Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation. NCT07028112n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Cohort NRP vs DHOPE vs COR-NMP in ECD-DCD Donation NCT05327478n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: NRP, DHOPE, COR-NMP Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs NCT04613921n/a106 sites📍 Los Angeles📍 Aurora📍 Tampa European Foundation for Study of Chronic Liver Failure · Tests: Observational Protocol Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial) NCT07169643Phase 31 site📍 Barcelona Fundacion Clinic per a la Recerca Biomédica · Tests: Darbepoetin (DP) The Effect of the Type of Conduit-duct Anastomosis Technique on the Postoperative Course in Patients Undergoing Liver Transplantation NCT06533592NA1 site📍 Warsaw Medical University of Warsaw · Tests: Continous suture technique, Interrupted suture technique Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989n/a3 sites📍 Budapest📍 Budapest📍 Budapest Semmelweis University Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients NCT05793203n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS Predictive Factors for Massive Transfusion During Liver Transplantation NCT05763446n/a2 sites📍 Rome📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation NCT06905054Phase 21 site📍 Scottsdale Mayo Clinic · Tests: Fenofibrate (drug), Blood draw for the laboratory assessment, MRI using a hepatobiliary phase contrast agent (Gd-EOB-DP… Design and Implementation of the Pediatric Liver Transplantation Biobank NCT04477967n/a1 site📍 Chongqing Children's Hospital of Chongqing Medical University · Tests: No intervention Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation NCT03789383n/a2 sites📍 Asyut📍 Asyut Assiut University Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903n/a1 site📍 Chicago Northwestern University MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation NCT06130046n/a1 site📍 Rome University of Rome Tor Vergata · Tests: MR-proADM dosage
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy